{
  "metrics": {
    "precision": 0.3333333333333333,
    "recall": 1.0,
    "f1": 0.5
  },
  "n": 4,
  "api_base": "http://127.0.0.1:8000",
  "results": [
    {
      "input": {
        "disease": "multiple myeloma",
        "therapy": "BRAF inhibitor",
        "drug_or_class": "",
        "gene": "BRAF",
        "hgvs_p": "V600E",
        "chrom": "7",
        "pos": "140453136",
        "ref": "T",
        "alt": "A",
        "build": "GRCh38",
        "on_label_truth": "false"
      },
      "prediction": {
        "therapy": "BRAF inhibitor",
        "disease": "multiple myeloma",
        "on_label": false,
        "tier": "research",
        "strength": "weak",
        "efficacy_score": 0.0,
        "confidence": 0.0,
        "insights": {
          "functionality": 0.0,
          "chromatin": 0.0,
          "essentiality": 0.0,
          "regulatory": 0.0
        },
        "rationale": [
          "MoA alignment: MAPK blockade",
          "evidence_strength=0.0",
          "citations_count=0"
        ],
        "citations": [],
        "evidence_tier": "insufficient",
        "badges": [],
        "provenance": {
          "efficacy_run": "28df0f5bae41",
          "source": "efficacy/predict"
        }
      }
    },
    {
      "input": {
        "disease": "multiple myeloma",
        "therapy": "MEK inhibitor",
        "drug_or_class": "",
        "gene": "KRAS",
        "hgvs_p": "G12D",
        "chrom": "12",
        "pos": "25398284",
        "ref": "G",
        "alt": "A",
        "build": "GRCh38",
        "on_label_truth": "false"
      },
      "prediction": {
        "therapy": "MEK inhibitor",
        "disease": "multiple myeloma",
        "on_label": false,
        "tier": "I",
        "strength": "strong",
        "efficacy_score": 0.32,
        "confidence": 0.85,
        "insights": {
          "functionality": 0.6,
          "chromatin": 0.6,
          "essentiality": 0.35,
          "regulatory": 0.1
        },
        "rationale": [
          "MoA alignment: MAPK downstream blockade",
          "evidence_strength=0.8",
          "citations_count=5"
        ],
        "citations": [
          "40459694",
          "40411938",
          "40707833"
        ],
        "evidence_tier": "supported",
        "badges": [],
        "provenance": {
          "efficacy_run": "a7b8139f9012",
          "source": "efficacy/predict"
        }
      }
    },
    {
      "input": {
        "disease": "multiple myeloma",
        "therapy": "MEK inhibitor",
        "drug_or_class": "",
        "gene": "NRAS",
        "hgvs_p": "Q61R",
        "chrom": "1",
        "pos": "115256529",
        "ref": "A",
        "alt": "G",
        "build": "GRCh38",
        "on_label_truth": "false"
      },
      "prediction": {
        "therapy": "MEK inhibitor",
        "disease": "multiple myeloma",
        "on_label": false,
        "tier": "I",
        "strength": "moderate",
        "efficacy_score": 0.29,
        "confidence": 0.83,
        "insights": {
          "functionality": 0.6,
          "chromatin": 0.6,
          "essentiality": 0.351,
          "regulatory": 0.101
        },
        "rationale": [
          "MoA alignment: MAPK downstream blockade",
          "evidence_strength=0.7",
          "citations_count=5"
        ],
        "citations": [
          "40159286",
          "40459694",
          "40411938"
        ],
        "evidence_tier": "supported",
        "badges": [],
        "provenance": {
          "efficacy_run": "a95dd7270419",
          "source": "efficacy/predict"
        }
      }
    },
    {
      "input": {
        "disease": "multiple myeloma",
        "therapy": "chemotherapy",
        "drug_or_class": "",
        "gene": "TP53",
        "hgvs_p": "R248W",
        "chrom": "17",
        "pos": "7577120",
        "ref": "C",
        "alt": "T",
        "build": "GRCh38",
        "on_label_truth": "true"
      },
      "prediction": {
        "therapy": "BRAF inhibitor",
        "disease": "multiple myeloma",
        "on_label": false,
        "tier": "I",
        "strength": "moderate",
        "efficacy_score": 0.255,
        "confidence": 0.74,
        "insights": {
          "functionality": 0.6,
          "chromatin": 0.6,
          "essentiality": 0.351,
          "regulatory": 0.101
        },
        "rationale": [
          "MoA alignment: MAPK blockade",
          "evidence_strength=0.75",
          "citations_count=5",
          "resistance:TP53_high_risk",
          "TP53 R248W confers chemotherapy resistance"
        ],
        "citations": [
          "40702960",
          "40512670",
          "40497952"
        ],
        "evidence_tier": "supported",
        "badges": [],
        "provenance": {
          "efficacy_run": "b2b8f7f38499",
          "source": "efficacy/predict"
        }
      }
    }
  ]
}